193 related articles for article (PubMed ID: 27902713)
1. Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
Chandler PD; Akinkuolie AO; Tobias DK; Lawler PR; Li C; Moorthy MV; Wang L; Duprez DA; Jacobs DR; Glynn RJ; Otvos J; Connelly MA; Post WS; Ridker PM; Manson JE; Buring JE; Lee IM; Mora S
PLoS One; 2016; 11(11):e0165615. PubMed ID: 27902713
[TBL] [Abstract][Full Text] [Related]
2. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.
Lawler PR; Akinkuolie AO; Chandler PD; Moorthy MV; Vandenburgh MJ; Schaumberg DA; Lee IM; Glynn RJ; Ridker PM; Buring JE; Mora S
Circ Res; 2016 Apr; 118(7):1106-15. PubMed ID: 26951635
[TBL] [Abstract][Full Text] [Related]
3. The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
Jang S; Ogunmoroti O; Zhao D; Fashanu OE; Tibuakuu M; Benson EM; Norby F; Otvos JD; Heckbert SR; Szklo M; Michos ED
PLoS One; 2021; 16(3):e0248644. PubMed ID: 33765041
[TBL] [Abstract][Full Text] [Related]
4. A novel protein glycan biomarker and future cardiovascular disease events.
Akinkuolie AO; Buring JE; Ridker PM; Mora S
J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
[TBL] [Abstract][Full Text] [Related]
5. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
[TBL] [Abstract][Full Text] [Related]
6. Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Kianoush S; Bittencourt MS; Lotufo PA; Bensenor IM; Jones SR; DeFilippis AP; Toth PP; Otvos JD; Tibuakuu M; Hall ME; Harada PHN; Blaha MJ
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838917
[TBL] [Abstract][Full Text] [Related]
7. Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.
Akinkuolie AO; Glynn RJ; Padmanabhan L; Ridker PM; Mora S
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27413042
[TBL] [Abstract][Full Text] [Related]
8. Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
Jang S; Ogunmoroti O; Ndumele CE; Zhao D; Rao VN; Fashanu OE; Tibuakuu M; Otvos JD; Benson EM; Ouyang P; Michos ED
Circ Heart Fail; 2020 Aug; 13(8):e007067. PubMed ID: 32762458
[TBL] [Abstract][Full Text] [Related]
9. GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis.
Gruppen EG; Kunutsor SK; Kieneker LM; van der Vegt B; Connelly MA; de Bock GH; Gansevoort RT; Bakker SJL; Dullaart RPF
J Intern Med; 2019 Nov; 286(5):596-609. PubMed ID: 31260573
[TBL] [Abstract][Full Text] [Related]
10. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
Prizment AE; Anderson KE; Visvanathan K; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
[TBL] [Abstract][Full Text] [Related]
11. Biomarker Glycoprotein Acetyls Is Associated With the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients.
Kettunen J; Ritchie SC; Anufrieva O; Lyytikäinen LP; Hernesniemi J; Karhunen PJ; Kuukasjärvi P; Laurikka J; Kähönen M; Lehtimäki T; Havulinna AS; Salomaa V; Männistö S; Ala-Korpela M; Perola M; Inouye M; Würtz P
Circ Genom Precis Med; 2018 Nov; 11(11):e002234. PubMed ID: 30571186
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events.
Duprez DA; Otvos J; Sanchez OA; Mackey RH; Tracy R; Jacobs DR
Clin Chem; 2016 Jul; 62(7):1020-31. PubMed ID: 27173011
[TBL] [Abstract][Full Text] [Related]
13. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study.
Connelly MA; Gruppen EG; Wolak-Dinsmore J; Matyus SP; Riphagen IJ; Shalaurova I; Bakker SJ; Otvos JD; Dullaart RP
Clin Chim Acta; 2016 Jan; 452():10-7. PubMed ID: 26549655
[TBL] [Abstract][Full Text] [Related]
14. Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi-Ethnic Study of Atherosclerosis.
Benson EA; Tibuakuu M; Zhao D; Akinkuolie AO; Otvos JD; Duprez DA; Jacobs DR; Mora S; Michos ED
Clin Cardiol; 2018 Nov; 41(11):1439-1445. PubMed ID: 30452775
[TBL] [Abstract][Full Text] [Related]
15. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.
Akinkuolie AO; Pradhan AD; Buring JE; Ridker PM; Mora S
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1544-50. PubMed ID: 25908766
[TBL] [Abstract][Full Text] [Related]
16. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL
Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983
[TBL] [Abstract][Full Text] [Related]
17. Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Harada PH; Benseñor IM; Bittencourt MS; Nasir K; Blaha MJ; Jones SR; Toth PP; Lotufo PA
J Cardiol; 2019 May; 73(5):408-415. PubMed ID: 30595405
[TBL] [Abstract][Full Text] [Related]
18. Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: The PREVEND study.
Gruppen EG; Connelly MA; Sluiter WJ; Bakker SJL; Dullaart RPF
Clin Chim Acta; 2019 Jan; 488():7-12. PubMed ID: 30365925
[TBL] [Abstract][Full Text] [Related]
19. GlycA, a novel proinflammatory glycoprotein biomarker, and high-sensitivity C-reactive protein are inversely associated with sodium intake after controlling for adiposity: the Prevention of Renal and Vascular End-Stage Disease study.
Gruppen EG; Connelly MA; Vart P; Otvos JD; Bakker SJ; Dullaart RP
Am J Clin Nutr; 2016 Aug; 104(2):415-22. PubMed ID: 27305953
[TBL] [Abstract][Full Text] [Related]
20. The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.
Ezeigwe A; Fashanu OE; Zhao D; Budoff MJ; Otvos JD; Thomas IC; Mora S; Tibuakuu M; Michos ED
Atherosclerosis; 2019 Mar; 282():91-99. PubMed ID: 30716566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]